Please check your internet connection and try again.
# Taxim (Cefotaxime)
## Overview
Cefotaxime is a third-generation cephalosporin antibiotic. It acts by inhibiting bacterial cell wall synthesis through binding to penicillin-binding proteins (PBPs). It possesses broad-spectrum activity against many Gram-positive and Gram-negative organisms but is not active against *Pseudomonas aeruginosa*.
## Primary Indications
* Lower respiratory tract infections
* Urinary tract infections (UTIs)
* Gynecological infections (e.g., pelvic inflammatory disease)
* Sepsis/bacteremia
* Meningitis (high CNS penetration)
* Skin and skin structure infections
* Perioperative prophylaxis
## Adult Dosing
* **Uncomplicated Infections:** 1 g IV/IM every 12 hours.
* **Moderate to Severe Infections:** 1–2 g IV/IM every 8 hours.
* **Life-Threatening Infections (e.g., Meningitis):** 2 g IV every 4–6 hours.
* **Maximum Dose:** 12 g per 24 hours.
## Pediatric Dosing (Neonates to <12 years)
* **Neonates (0–1 week):** 50 mg/kg IV every 12 hours.
* **Neonates (1–4 weeks):** 50 mg/kg IV every 8 hours.
* **Infants and Children (1 month–12 years):** 50–180 mg/kg/day divided every 4–6 hours (max 12 g/day).
* *Note: Dosing for meningitis is typically at the higher end of the range.*
## Dose Adjustments
* **Renal Impairment:** If CrCl <20 mL/min, reduce the maintenance dose by 50%.
* **Hepatic Impairment:** No specific adjustment required; use with caution.
## Contraindications
* Hypersensitivity to cefotaxime or other cephalosporins.
* History of anaphylaxis to penicillins or other beta-lactams (cross-reactivity risk is low but clinically significant).
## Adverse Effects
* **Common:** Injection site reactions (phlebitis/pain), diarrhea, nausea, rash.
* **Serious:** *Clostridioides difficile*-associated diarrhea, hypersensitivity reactions (anaphylaxis, serum sickness), seizure (at high doses/renal failure), neutropenia, elevated liver enzymes.
## Key Drug Interactions
* **Aminoglycosides:** Potential for increased nephrotoxicity.
* **Probenecid:** Inhibits renal excretion, increasing cefotaxime serum levels.
* **BCG Vaccine (Live):** Antibiotics may decrease the therapeutic effect of the vaccine.
## Monitoring
* Renal function (BUN/SCr).
* Complete blood count (CBC) during prolonged therapy (monitor for neutropenia).
* Signs of superinfection (e.g., C. diff, fungal overgrowth).
* Liver function tests (LFTs) if therapy is extended.
## Clinical Pearls
* **CNS Penetration:** Excellent penetration into the cerebrospinal fluid (CSF), making it a gold standard for pediatric meningitis caused by susceptible organisms.
* **Administration:** IM injections should be made deep into a large muscle mass to minimize pain. IV doses can be administered as a slow push (3–5 minutes) or infusion (20–30 minutes).
* **Spectrum:** While potent against Gram-negatives, it lacks *Pseudomonas* coverage; if *Pseudomonas* is suspected, consider ceftazidime or cefepime.
* **Local Protocols:** Always verify empiric dosing against local institutional antibiograms, as resistance patterns vary significantly by geographic region.
***
*Disclaimer: This information is for educational purposes only. Always consult current FDA-approved labeling or institutional prescribing guidelines before administering medication to ensure clinical safety and efficacy.*
